These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23141913)

  • 1. Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
    Aguilar N; Mir M; Grima PM; López M; Segarra V; Esteban L; Moreno I; Godessart N; Tarrasón G; Domenech T; Vilella D; Armengol C; Córdoba M; Sabaté M; Casals D; Domínguez M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7672-6. PubMed ID: 23141913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)).
    Ren F; Deng G; Wang H; Luan L; Meng Q; Xu Q; Xu H; Xu X; Zhang H; Zhao B; Li C; Guo TB; Yang J; Zhang W; Zhao Y; Jia Q; Lu H; Xiang JN; Elliott JD; Lin X
    J Med Chem; 2012 May; 55(9):4286-96. PubMed ID: 22500954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptor.
    Xu H; Zhang H; Luan L; Xu Y; Li C; Wang Y; Han F; Yang T; Ren F; Xiang JN; Elliott JD; Zhao Y; Guo TB; Lu H; Zhang W; Hirst D; Lindon M; Lin X
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2456-9. PubMed ID: 22386243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1.
    Evindar G; Deng H; Bernier SG; Doyle E; Lorusso J; Morgan BA; Westlin WF
    Bioorg Med Chem Lett; 2013 Jan; 23(2):472-5. PubMed ID: 23245510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist.
    Nakamura T; Asano M; Sekiguchi Y; Mizuno Y; Tamaki K; Kimura T; Nara F; Kawase Y; Shimozato T; Doi H; Kagari T; Tomisato W; Inoue R; Nagasaki M; Yuita H; Oguchi-Oshima K; Kaneko R; Watanabe N; Abe Y; Nishi T
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1788-92. PubMed ID: 22264485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists.
    Colandrea VJ; Legiec IE; Huo P; Yan L; Hale JJ; Mills SG; Bergstrom J; Card D; Chebret G; Hajdu R; Keohane CA; Milligan JA; Rosenbach MJ; Shei GJ; Mandala SM
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2905-8. PubMed ID: 16580205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists.
    Evindar G; Bernier SG; Doyle E; Kavarana MJ; Satz AL; Lorusso J; Blanchette HS; Saha AK; Hannig G; Morgan BA; Westlin WF
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2520-4. PubMed ID: 20304639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel series of potent S1P1 agonists.
    Crosignani S; Bombrun A; Covini D; Maio M; Marin D; Quattropani A; Swinnen D; Simpson D; Sauer W; Françon B; Martin T; Cambet Y; Nichols A; Martinou I; Burgat-Charvillon F; Rivron D; Donini C; Schott O; Eligert V; Novo-Perez L; Vitte PA; Arrighi JF
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1516-9. PubMed ID: 20149651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
    Horan JC; Sanyal S; Choi Y; Hill-Drzewi M; Patnaude L; Anderson S; Fogal S; Mao C; Cook BN; Gueneva-Boucheva K; Fisher MB; Hickey E; Pack E; Bannen LC; Chan DS; Mac MB; Ng SM; Wang Y; Xu W; Modis LK; Lemieux RM
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4807-11. PubMed ID: 25241927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis.
    Quancard J; Bollbuck B; Janser P; Angst D; Berst F; Buehlmayer P; Streiff M; Beerli C; Brinkmann V; Guerini D; Smith PA; Seabrook TJ; Traebert M; Seuwen K; Hersperger R; Bruns C; Bassilana F; Bigaud M
    Chem Biol; 2012 Sep; 19(9):1142-51. PubMed ID: 22999882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy.
    Quattropani A; Sauer WH; Crosignani S; Dorbais J; Gerber P; Gonzalez J; Marin D; Muzerelle M; Beltran F; Nichols A; Georgi K; Schneider M; Vitte PA; Eligert V; Novo-Perez L; Hantson J; Nock S; Carboni S; de Souza AL; Arrighi JF; Boschert U; Bombrun A
    ChemMedChem; 2015 Apr; 10(4):688-714. PubMed ID: 25735812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists.
    Evindar G; Bernier SG; Kavarana MJ; Doyle E; Lorusso J; Kelley MS; Halley K; Hutchings A; Wright AD; Saha AK; Hannig G; Morgan BA; Westlin WF
    Bioorg Med Chem Lett; 2009 Jan; 19(2):369-72. PubMed ID: 19081720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.
    Hale JJ; Lynch CL; Neway W; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Parent SA; Chrebet G; Bergstrom J; Card D; Ferrer M; Hodder P; Strulovici B; Rosen H; Mandala S
    J Med Chem; 2004 Dec; 47(27):6662-5. PubMed ID: 15615513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of S1P agonists with a dihydronaphthalene scaffold.
    Kurata H; Kusumi K; Otsuki K; Suzuki R; Kurono M; Takada Y; Shioya H; Komiya T; Mizuno H; Ono T; Hagiya H; Minami M; Nakade S; Habashita H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3885-9. PubMed ID: 21641216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists.
    Evindar G; Satz AL; Bernier SG; Kavarana MJ; Doyle E; Lorusso J; Taghizadeh N; Halley K; Hutchings A; Kelley MS; Wright AD; Saha AK; Hannig G; Morgan BA; Westlin WF
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2315-9. PubMed ID: 19282175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.
    Bolli MH; Abele S; Binkert C; Bravo R; Buchmann S; Bur D; Gatfield J; Hess P; Kohl C; Mangold C; Mathys B; Menyhart K; Müller C; Nayler O; Scherz M; Schmidt G; Sippel V; Steiner B; Strasser D; Treiber A; Weller T
    J Med Chem; 2010 May; 53(10):4198-211. PubMed ID: 20446681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fused tricyclic indoles as S1P₁ agonists with robust efficacy in animal models of autoimmune disease.
    Buzard DJ; Han S; Lopez L; Kawasaki A; Moody J; Thoresen L; Ullman B; Lehmann J; Calderon I; Zhu X; Gharbaoui T; Sengupta D; Krishnan A; Gao Y; Edwards J; Barden J; Morgan M; Usmani K; Chen C; Sadeque A; Thatte J; Solomon M; Fu L; Whelan K; Liu L; Al-Shamma H; Gatlin J; Le M; Xing C; Espinola S; Jones RM
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4404-9. PubMed ID: 22633692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes.
    Yan L; Huo P; Doherty G; Toth L; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Quackenbush E; Wickham A; Mandala SM
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3679-83. PubMed ID: 16697189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists.
    Meng Q; Zhao B; Xu Q; Xu X; Deng G; Li C; Luan L; Ren F; Wang H; Xu H; Xu Y; Zhang H; Xiang JN; Elliott JD; Guo TB; Zhao Y; Zhang W; Lu H; Lin X
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2794-7. PubMed ID: 22429468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation.
    Piali L; Froidevaux S; Hess P; Nayler O; Bolli MH; Schlosser E; Kohl C; Steiner B; Clozel M
    J Pharmacol Exp Ther; 2011 May; 337(2):547-56. PubMed ID: 21345969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.